Vireo Growth (VREOF) Accounts Payables (2020 - 2026)
Vireo Growth's (VREOF) quarterly Accounts Payables came in at $20.7 million in Q1 2026, up 69.71% year-on-year from $12.2 million in Q1 2025, and up 8.95% quarter-over-quarter from $19.0 million in Q4 2025.
Vireo Growth (VREOF) Accounts Payables (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Accounts Payables across 7 years of filings, most recently posting $20.7 million for Q1 2026.
- Accounts Payables for Q1 2026 came in at $20.7 million, up 69.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.7 million (up 69.71% YoY), and the FY2025 annual result was $19.0 million, up 81.71% from the prior year.
- Accounts Payables came in at $20.7 million for Q1 2026 at Vireo Growth, up from $19.0 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $47.5 million in Q2 2025 to a low of $1.5 million in Q3 2023.
- The 5-year median for Accounts Payables is $10.5 million (2024), against an average of $14.1 million.
- Peak annual rise in Accounts Payables reached 971.18% in 2023, while the deepest fall reached 91.44% in 2023.
- Vireo Growth's Accounts Payables stood at $14.9 million in 2022, then plunged by 48.59% to $7.7 million in 2023, then jumped by 36.25% to $10.5 million in 2024, then surged by 81.71% to $19.0 million in 2025, then gained by 8.95% to $20.7 million in 2026.
- The last three Accounts Payables figures came in at $20.7 million (Q1 2026), $19.0 million (Q4 2025), and $38.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn | 20.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.70 Mn |
| Dec 31, 2025 | 19.00 Mn |
| Sep 30, 2025 | 38.54 Mn |
| Jun 30, 2025 | 47.45 Mn |
| Mar 31, 2025 | 12.20 Mn |
| Dec 31, 2024 | 10.46 Mn |
| Sep 30, 2024 | 3.76 Mn |
| Jun 30, 2024 | 9.18 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 7.67 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 27.09 Mn |
| Mar 31, 2023 | 1.60 Mn |
| Dec 31, 2022 | 14.93 Mn |
| Sep 30, 2022 | 17.24 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 10.01 Mn |